Gilead Sciences, Inc.
CH ˙ SWX ˙ US3755581036
SecurityCH:GILD / Gilead Sciences, Inc.
InstitutionNoesis Capital Mangement Corp
Latest Disclosed Ownership115,229 shares
Latest Disclosed Value $ 16,059,528
Noesis Capital Mangement Corp reports 0.03% decrease in ownership of GILD / Gilead Sciences, Inc.

On May 5, 2026 - Noesis Capital Mangement Corp filed a 13F-HR form disclosing ownership of 115,229 shares of Gilead Sciences, Inc. (CH:GILD) valued at $16,059,528 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 5, 2026 disclosing 115,263 shares of Gilead Sciences, Inc.. This represents a change in shares of -0.03% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-05 2026-03-31 13F GILEAD SCIENCES COM 375558103 115,229 -34 -0.03 16,060 13.52 2.3743
2026-02-05 2025-12-31 13F GILEAD SCIENCES COM 375558103 115,263 745 0.65 14,147 11.30 2.0516
2025-10-23 2025-09-30 13F GILEAD SCIENCES COM 375558103 114,518 943 0.83 12,712 0.95 1.9733
2025-08-04 2025-06-30 13F GILEAD SCIENCES COM 375558103 113,575 116 0.10 12,592 -0.95 2.1869
2025-05-07 2025-03-31 13F/A-1 GILEAD SCIENCES COM 375558103 113,459 -1,380 -1.20 12,713 19.85 2.5285
2025-05-06 2025-03-31 13F GILEAD SCIENCES COM 375558103 113,459 -1,380 12,713 2.5285
2025-02-05 2024-12-31 13F GILEAD SCIENCES COM 375558103 114,839 -1,274 -1.10 10,608 8.97 2.0242
2024-11-14 2024-09-30 13F GILEAD SCIENCES COM 375558103 116,113 4,425 3.96 9,735 27.04 1.9322
2024-08-05 2024-06-30 13F Gilead Sciences COMMON STOCKS 375558103 111,688 20 0.02 7,663 -6.32 1.6991
2024-05-03 2024-03-31 13F Gilead Sciences COMMON STOCKS 375558103 111,668 5,223 4.91 8,180 -5.15 1.8166
2024-02-06 2023-12-31 13F Gilead Sciences COMMON STOCKS 375558103 106,445 -1,408 -1.31 8,623 6.69 2.0328
2023-11-03 2023-09-30 13F/A-1 Gilead Sciences COMMON STOCKS 375558103 107,853 507 0.47 8,083 -2.31 2.1197
2023-11-03 2023-09-30 13F Gilead Sciences COMMON STOCKS 375558103 107,853 507 8,083 2.1197
2023-07-31 2023-06-30 13F Gilead Sciences COMMON STOCKS 375558103 107,346 118 0.11 8,273 -7.01 2.0367
2023-05-08 2023-03-31 13F Gilead Sciences COMMON STOCKS 375558103 107,228 4,325 4.20 8,897 0.71 2.2532
2023-02-02 2022-12-31 13F Gilead Sciences COMMON STOCKS 375558103 102,903 -4,201 -3.92 8,834 33.71 2.5109
2022-11-01 2022-09-30 13F Gilead Sciences COMMON STOCKS 375558103 107,104 -493 -0.46 6,607 -0.66 2.0023
2022-07-29 2022-06-30 13F Gilead Sciences COMMON STOCKS 375558103 107,597 -1,622 -1.49 6,651 2.43 1.9731
2022-05-05 2022-03-31 13F Gilead Sciences COMMON STOCKS 375558103 109,219 -1,099 -1.00 6,493 -18.94 1.5621
2022-02-03 2021-12-31 13F Gilead Sciences COMMON STOCKS 375558103 110,318 -15,554 -12.36 8,010 -8.89 1.6141
2021-11-04 2021-09-30 13F Gilead Sciences COMMON STOCKS 375558103 125,872 1,699 1.37 8,792 3.17 1.7171
2021-08-05 2021-06-30 13F Gilead Sciences COMMON STOCKS 375558103 124,173 315 0.25 8,522 6.46 1.7420
2021-05-06 2021-03-31 13F Gilead Sciences COMMON STOCKS 375558103 123,858 -3,440 -2.70 8,005 7.94 1.7975
2021-02-04 2020-12-31 13F Gilead Sciences COMMON STOCKS 375558103 127,298 -3,230 -2.47 7,416 -10.09 1.8323
2020-11-05 2020-09-30 13F Gilead Sciences COMMON STOCKS 375558103 130,528 -2,882 -2.16 8,248 -19.65 2.3353
2020-08-07 2020-06-30 13F Gilead Sciences COMMON STOCKS 375558103 133,410 -6,241 -4.47 10,265 -1.68 3.2456
2020-05-06 2020-03-31 13F Gilead Sciences COMMON STOCKS 375558103 139,651 373 0.27 10,440 15.36 3.8409
2020-02-07 2019-12-31 13F Gilead Sciences COMMON STOCKS 375558103 139,278 874 0.63 9,050 3.17 2.5217
2019-11-05 2019-09-30 13F Gilead Sciences COMMON STOCKS 375558103 138,404 931 0.68 8,772 -5.56 2.8363
2019-08-06 2019-06-30 13F Gilead Sciences COMMON STOCKS 375558103 137,473 926 0.68 9,288 4.63 3.1649
2019-05-09 2019-03-31 13F Gilead Sciences COMMON STOCKS 375558103 136,547 37,112 37.32 8,877 42.72 3.2104
2019-02-08 2018-12-31 13F GILEAD SCIENCES COM 375558103 99,435 1,549 1.58 6,220 -17.70 2.5242
2018-11-15 2018-09-30 13F GILEAD SCIENCES COM 375558103 97,886 4,781 5.14 7,558 14.58 2.6489
2018-08-13 2018-06-30 13F GILEAD SCIENCES COM 375558103 93,105 -9,742 -9.47 6,596 -14.93 2.4205
2018-05-07 2018-03-31 13F GILEAD SCIENCES COM 375558103 102,847 2,528 2.52 7,754 7.89 2.8738
2018-02-21 2017-12-31 13F/A-1 GILEAD SCIENCES COM 375558103 100,319 -1,705 -1.67 7,187 -13.05 2.5859
2018-02-14 2017-12-31 13F GILEAD SCIENCES COM 375558103 100,319 -1,705 7,187
2017-11-07 2017-09-30 13F GILEAD SCIENCES COM 375558103 102,024 -1,724 -1.66 8,266 12.57 3.1021
2017-08-10 2017-06-30 13F GILEAD SCIENCES COM 375558103 103,748 -2,107 -1.99 7,343 2.13 2.8133
2017-05-10 2017-03-31 13F GILEAD SCIENCES COM 375558103 105,855 -2,284 -2.11 7,190 -7.15 2.7398
2017-02-08 2016-12-31 13F GILEAD SCIENCES COM 375558103 108,139 40,029 58.77 7,744 43.70 3.2330
2016-11-03 2016-09-30 13F GILEAD SCIENCES COM 375558103 68,110 1,585 2.38 5,389 -2.90 2.3198
2016-08-04 2016-06-30 13F GILEAD SCIENCES COM 375558103 66,525 726 1.10 5,550 -8.17 2.4698
2016-05-04 2016-03-31 13F GILEAD SCIENCES COM 375558103 65,799 827 1.27 6,044 -8.08 2.7511
2016-02-08 2015-12-31 13F GILEAD SCIENCES COM 375558103 64,972 1,655 2.61 6,575 5.76 3.1249
2015-11-12 2015-09-30 13F GILEAD SCIENCES COM 375558103 63,317 -6,070 -8.75 6,217 -23.47 3.2888
2015-08-06 2015-06-30 13F GILEAD SCIENCES COM 375558103 69,387 -776 -1.11 8,124 18.00 3.5021
2015-05-06 2015-03-31 13F Gilead Sciences COMMON STOCKS 375558103 70,163 715 1.03 6,885 5.18 2.8499
2015-02-10 2014-12-31 13F Gilead Sciences COMMON STOCKS 375558103 69,448 6,995 11.20 6,546 -1.53 2.7434
2014-11-04 2014-09-30 13F Gilead Sciences COMMON STOCKS 375558103 62,453 -3,411 -5.18 6,648 21.74 2.8921
2014-07-31 2014-06-30 13F Gilead Sciences COMMON STOCKS 375558103 65,864 58,048 742.68 5,461 885.74 2.4652
2014-04-30 2014-03-31 13F Gilead Sciences COMMON STOCKS 375558103 7,816 1,888 31.85 554 24.49 0.2722
2014-02-10 2013-12-31 13F Gilead Sciences COM 375558103 5,928 -3,121 -34.49 445 0.2192
2013-11-06 2013-09-30 13F Gilead Sciences COM 375558103 9,049 0 0.00 1 0.3000
2013-08-06 2013-06-30 13F Gilead Sciences COM 375558103 9,049 9,049 0 0.2478
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.